Cognition Therapeutics (CGTX)
US Market

Cognition Therapeutics Financial Statements

Cognition Therapeutics Financial Overview

Cognition Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.86; its P/E ratio is -3.08; Cognition Therapeutics is scheduled to report earnings on May 11, 2022, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -3.70M$ -7.34M$ -3.11M$ -1.13M$ 760.00K
EBITDA$ -3.65M$ -7.32M$ -3.09M$ -1.11M$ 783.00K
Net Income Common Stockholders$ -3.84M$ -7.54M$ -4.97M$ -2.83M$ -905.00K
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 5.19M$ 8.31M$ 11.30M$ 13.37M$ 51.51M
Total Assets$ 58.70M$ 59.14M$ 13.39M$ 17.29M$ 16.51M
Total Debt$ 1.40M$ 12.69M$ 12.85M$ 0.00$ 0.00
Net Debt$ -3.79M$ 4.38M$ 1.55M$ -13.37M$ -51.51M
Total Liabilities$ 9.96M$ 7.86M$ 100.11M$ 100.97M$ 84.37M
Stockholders Equity$ 48.74M$ 51.27M$ -86.72M$ -83.68M$ -67.85M
Cash Flow
Free Cash Flow$ -3.12M$ 74.00K$ -2.05M$ -910.00K$ -772.00K
Operating Cash Flow$ -2.99M$ 101.00K$ -2.05M$ -910.00K$ -772.00K
Investing Cash Flow$ -134.00K$ -27.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ -91.00K$ 46.36M$ -961.00K$ -1.16M$ 8.96M
Currency in USD

Cognition Therapeutics Earnings and Revenue History

Cognition Therapeutics Debt to Assets

Cognition Therapeutics Cash Flow

Cognition Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis